NINTEDANIB FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS - INITIAL CLINICAL EXPERIENCE IN A UK COHORT

被引：4
|
作者：
Fletcher, S. V. [1 ]
Jones, M. G. [1 ]
Renzoni, E. [2 ]
Parfrey, H. [3 ]
Hoyles, R. [4 ]
Spinks, K. [5 ]
Kokosi, M.
Kwok, A. [6 ]
Warburton, C. [6 ]
Titmuss, V. [5 ]
Maher, T. [2 ]
Chua, F. [2 ]
Wells, A. [2 ]
Richeldi, L. [1 ]
Spencer, L. G. [6 ]
机构：
[1] Southampton Univ Hosp, Southampton, Hants, England
[2] Royal Brampton Hosp, ILD Unit, London, England
[3] Papworth Hosp, Cambridge CB3 8RE, England
[4] John Radcliffe Hosp, Oxford, England
[5] Queen Alexandra Hosp, Portsmouth, Hants, England
[6] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
来源：
THORAX | 2015年 / 70卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1136/thoraxjnl-2015-207770.146
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P9
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [21] Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
    Wollin, Lutz
    Wex, Eva
    Pautsch, Alexander
    Schnapp, Gisela
    Hostettler, Katrin E.
    Stowasser, Susanne
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1434 - 1445
  • [22] Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis
    Brunnemer, Eva
    Ehlers-Tenenbaum, Svenja
    Heussel, Calus Peter
    Warth, Arne
    Herth, Felix
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] Appropriateness Of Prescribing Nintedanib For Idiopathic Pulmonary Fibrosis - An Institutional Experience
    Yau, S.
    Raheem, S.
    Rueda, A.
    Pandit, L.
    Bujarski, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Bonella, Francesco
    Wessendorf, Thomas
    Costabel, Ulrich
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Bonella, F.
    Wessendorf, T. E.
    Costabel, U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (11) : 518 - 523
  • [27] A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
    Rinciog, C.
    Watkins, M.
    Chang, S.
    Maher, T. M.
    LeReun, C.
    Esser, D.
    Diamantopoulos, A.
    PHARMACOECONOMICS, 2017, 35 (04) : 479 - 491
  • [28] A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
    C. Rinciog
    M. Watkins
    S. Chang
    T. M. Maher
    C. LeReun
    D. Esser
    A. Diamantopoulos
    PharmacoEconomics, 2017, 35 : 479 - 491
  • [29] Nintedanib for the Idiopathic Pulmonary Fibrosis with Emphysema
    Krome, Susanne
    PNEUMOLOGIE, 2019, 73 (03):
  • [30] Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
    Antonio Rodriguez-Portal, Jose
    DRUGS IN R&D, 2018, 18 (01) : 19 - 25
12345